APA (7th ed.) Citation

H, P., W, B., S, S., L, H., L, R., M, S., . . . F, L. (2026). Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR: :ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease. Leukemia & lymphoma, 1. https://doi.org/10.1080/10428194.2026.2707442

Chicago Style (17th ed.) Citation

H, Pfeifer, et al. "Efficacy of Imatinib Maintenance After Stem Cell Transplantation for Ph+/BCR: :ABL1 Positive ALL: Long-term Outcome of a Randomized Trial and Impact of Peritransplant Minimal Residual Disease." Leukemia & Lymphoma 2026: 1. https://doi.org/10.1080/10428194.2026.2707442.

MLA (9th ed.) Citation

H, Pfeifer, et al. "Efficacy of Imatinib Maintenance After Stem Cell Transplantation for Ph+/BCR: :ABL1 Positive ALL: Long-term Outcome of a Randomized Trial and Impact of Peritransplant Minimal Residual Disease." Leukemia & Lymphoma, 2026, p. 1, https://doi.org/10.1080/10428194.2026.2707442.